Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New President Of Ono Pharmaceutical Looks To Expand Overseas

This article was originally published in PharmAsia News

Executive Summary

Ono Pharmaceutical names current Managing Director and Director of Research Headquarters Daikichi Fukushima, as its new president effective June 27th. Current President Toshiharu Korekane will resign for health reasons and will become a special advisor to the company. Fukushima joined the company in 1978 after receiving a PhD in natural science from Tsukuba University. He became the director of research in 2006. Fukushima commented on his intention to further expand into overseas markets and promote drug development in the U.S. and Europe. Fukushima said after two years, Ono will have more overseas projects than domestic projects. (Click here for more - Japanese language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts